Publikationer 
                    
                    
                
            
                
    
            
2023
                            
                                
                                    
                                        Isabella Visuri, Carl Eriksson, Sara Karlqvist, Byron Lykiardopoulos, Per Karlen, Olof Grip, Charlotte Soderman, Sven Almer, Erik Hertervig, Jan Marsal, Carolina Malmgren, Jenny Delin, Hans Strid, Mats Sjoberg, Daniel Bergemalm, Henrik Hjortswang, Jonas Halfvarson
(2023)                                    
                                    
                                        Long-term outcomes of vedolizumab in inflammatory bowel disease: the Swedish prospective multicentre SVEAH extension study
                                    
                                
                                    
                                        Therapeutic Advances in Gastroenterology, Vol. 16, Artikel 17562848231174953
                                            
                                                (Artikel i tidskrift)
                                            
                                            
                                                
                                                    
                                                    Vidare till DOI
                                                
                                            
                                    
                            
2021
                            
                                
                                    
                                        Carl Eriksson, Sara Rundquist, Vyron Lykiardopoulos, Ruzan Udumyan, Per Karlen, Olof Grip, Charlotte Soderman, Sven Almer, Erik Hertervig, Jan Marsal, Jenny Gunnarsson, Carolina Malmgren, Jenny Delin, Hans Strid, Mats Sjoberg, David Oberg, Daniel Bergemalm, Henrik Hjortswang, Jonas Halfvarson
(2021)                                    
                                    
                                        Real-world effectiveness of vedolizumab in inflammatory bowel disease: week 52 results from the Swedish prospective multicentre SVEAH study
                                    
                                
                                    
                                        Therapeutic Advances in Gastroenterology, Vol. 14, Artikel 17562848211023386
                                            
                                                (Artikel i tidskrift)
                                            
                                            
                                                
                                                    
                                                    Vidare till DOI